Earnings Call Summary | Five9(FIVN.US) Q3 2024 Earnings Conference
Earnings Call Summary | Five9(FIVN.US) Q3 2024 Earnings Conference
Five9 is emphasizing AI integration across its services, with AI products now comprising over 20% of enterprise new logo ACV bookings in Q3.The following is a summary of the Five9, Inc. (FIVN) Q3 2024 Earnings Call Transcript:
以下是Five9, Inc. (FIVN) 2024年第三季度業績發佈會記錄的總結：
Financial Performance:
財務表現：
Five9 reported accelerated third-quarter total revenue growth of 15%, with subscription revenue growth notably increasing to 20% year-over-year.
Adjusted EBITDA margin reached 20% of revenue, significantly contributing to record quarterly operating cash flow of $41 million, representing 16% of revenue.
Five9報告第三季度總營業收入增長加速，增長率爲15%，訂閱營業收入增長顯著提升至同比20%。
調整後的EBITDA利潤率達到營業收入的20%，爲創紀錄的季度經營現金流4100萬美元做出了重要貢獻，代表營業收入的16%。
Business Progress:
業務進展：
Five9 is emphasizing AI integration across its services, with AI products now comprising over 20% of enterprise new logo ACV bookings in Q3.
The company successfully closed the acquisition of Acqueon, enhancing its intelligent CX platform capabilities.
Announced the launch of next-generation IVA under the Five9 AI agents, expected to elevate customer interactions with higher autonomy and comprehensive coverage across communication channels.
Five9強調在其服務中整合人工智能，第三季度人工智能產品的企業新商機年合同價值（ACV）預訂現在佔超過20%。
公司成功完成對Acqueon的收購，增強了其智能客戶體驗平台的能力。
宣佈推出下一代IVA，隸屬於Five9人工智能代理，預計將提高客戶互動的自主性，並全面覆蓋各溝通渠道。
Opportunities:
機會：
AI product momentum and the strategic acquisition of Acqueon provide substantial opportunities for market leadership in AI-powered CX and expansion in new verticals like healthcare.
人工智能產品的勢頭以及對Acqueon的戰略收購爲人工智能驅動的客戶體驗市場領導地位提供了實質機會，並在醫療等新垂直領域擴展。
Risks:
風險：
Potential delays in customer decision-making and budget constraints amid macroeconomic uncertainties could affect growth and sales cycles.
在宏觀經濟不確定性中，客戶決策的潛在延遲和預算限制可能會影響增長和銷售週期。
More details: Five9 IR
更多細節：Five9投資者關係
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更全面的細節，請參閱IR網站。 文章僅供投資者參考，不構成任何指導或推薦建議。
譯文內容由第三人軟體翻譯。
